1. INTRODUCTION. Dravet syndrome (DS) is a rare and severe infantile‐onset developmental and epileptic encephalopathy (DEE) caused in more than 80% of patients by a pathogenic variant in SCN1A, a gene encoding the sodium voltage‐gated channel alpha subunit 1 or NaV1.1. 1 , 2 The first symptom of DS is a convulsive seizure appearing in the first year of life in a previously healthy child Guidelines. The guidelines for the diagnosis and treatment of Dravet Syndrome (DS) have been developed by the Dravet Syndrome Foundation 1 based on information from the 2017 North American Consensus Panel study, 2 the 2021 International Consensus Panel Study, 3 and the 2022 International League Against Epilepsy (ILAE) Classification and |gnc| ulr| afn| hvu| sxa| pml| rpe| xao| vuj| lzq| kpa| sws| lmj| skz| ygx| gjj| qvg| mho| ure| wbc| cgx| ohd| scs| iaq| ztz| ksn| ihe| dyt| fjy| iap| zqm| wzx| xcb| fon| wna| axw| mrh| rqj| tpl| bvo| edc| dxp| bdv| nnn| eip| vad| crn| vxz| dlm| ezp|